Haddad Maia, the world number 99, provided a
sample for testing on June 4 during the Croatia Open that was
found to contain selective androgen receptor modulators (SARMs).
SARMs, which have similar properties to anabolic steroids, are
prohibited by the World Anti-Doping Agency.
The Brazilian qualified for the Wimbledon main draw in July and
beat former champion Garbine Muguruza in the first round.
She was informed of the finding on July 12, eight days after
being beaten by Britain's Harriet Dart in the second round of
the grass court Grand Slam, and her provisional suspension came
into effect on Monday.
"Ms. Haddad Maia had (and retains) the right to apply to the
Chair of the Independent Tribunal convened to hear her case why
the provisional suspension should not be imposed, but has chosen
not to exercise that right to date," the ITF said https://www.itftennis.com/news/309220.aspx.
(Reporting by Simon Jennings in Bengaluru; editing by Sudipto
Ganguly)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|